首页> 美国卫生研究院文献>PLoS Clinical Trials >A Method for Producing Transgenic Cells Using a Multi-Integrase System on a Human Artificial Chromosome Vector
【2h】

A Method for Producing Transgenic Cells Using a Multi-Integrase System on a Human Artificial Chromosome Vector

机译:一种在人类人工染色体载体上使用多整合酶系统生产转基因细胞的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The production of cells capable of expressing gene(s) of interest is important for a variety of applications in biomedicine and biotechnology, including gene therapy and animal transgenesis. The ability to insert transgenes at a precise location in the genome, using site-specific recombinases such as Cre, FLP, and ΦC31, has major benefits for the efficiency of transgenesis. Recent work on integrases from ΦC31, R4, TP901-1 and Bxb1 phages demonstrated that these recombinases catalyze site-specific recombination in mammalian cells. In the present study, we examined the activities of integrases on site-specific recombination and gene expression in mammalian cells. We designed a human artificial chromosome (HAC) vector containing five recombination sites (ΦC31 attP, R4 attP, TP901-1 attP, Bxb1 attP and FRT; multi-integrase HAC vector) and de novo mammalian codon-optimized integrases. The multi-integrase HAC vector has several functions, including gene integration in a precise locus and avoiding genomic position effects; therefore, it was used as a platform to investigate integrase activities. Integrases carried out site-specific recombination at frequencies ranging from 39.3–96.8%. Additionally, we observed homogenous gene expression in 77.3–87.5% of colonies obtained using the multi-integrase HAC vector. This vector is also transferable to another cell line, and is capable of accepting genes of interest in this environment. These data suggest that integrases have high DNA recombination efficiencies in mammalian cells. The multi-integrase HAC vector enables us to produce transgene-expressing cells efficiently and create platform cell lines for gene expression.
机译:能够表达目的基因的细胞的产生对于生物医学和生物技术的各种应用(包括基因治疗和动物转基因)很重要。使用位点特异性重组酶(例如Cre,FLP和ΦC31)将转基因插入基因组精确位置的能力,对转基因效率具有重大优势。关于ΦC31,R4,TP901-1和Bxb1噬菌体整合的最新研究表明,这些重组酶催化哺乳动物细胞中的位点特异性重组。在本研究中,我们检查了哺乳动物细胞中整合蛋白对位点特异性重组和基因表达的活性。我们设计了包含五个重组位点(ΦC31attP,R4 attP,TP901-1 attP,Bxb1 attP和FRT;多整合HAC载体)的人类人工染色体(HAC)载体和从头进行哺乳动物密码子优化的整合。多整合酶HAC载体具有多种功能,包括在精确位点进行基因整合和避免基因组位置效应。因此,它被用作调查整合酶活动的平台。积分以39.3–96.8%的频率进行位点特异性重组。此外,我们观察到使用多整合酶HAC载体获得的菌落中77.3–87.5%的基因表达均一。该载体也可转移至另一细胞系,并能够在该环境中接受目的基因。这些数据表明整合在哺乳动物细胞中具有高的DNA重组效率。多整合酶HAC载体使我们能够高效生产表达转基因的细胞,并创建用于基因表达的平台细胞系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号